Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,771 | 70,012 | 63,374 | 63,193 | 53,514 |
| Receivables | 53,568 | 42,258 | 44,895 | 40,936 | 38,512 |
| Inventories | 76,842 | 71,813 | 72,534 | 67,243 | 61,264 |
| TOTAL | $192,807 | $194,979 | $188,294 | $177,616 | $162,190 |
| Non-Current Assets | |||||
| PPE Net | 43,214 | 44,680 | 41,966 | 35,988 | 31,120 |
| Intangibles | 198,819 | 192,059 | 194,130 | 195,844 | 197,383 |
| Other Non-Current Assets | 14,882 | 14,852 | 14,779 | 14,482 | 14,568 |
| TOTAL | $256,915 | $251,591 | $250,875 | $246,314 | $243,071 |
| Total Assets | $449,722 | $446,570 | $439,169 | $423,930 | $405,261 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,701 | 13,103 | 16,714 | 15,348 | 11,969 |
| Accrued Expenses | 21,953 | 14,026 | 12,634 | 10,581 | 16,661 |
| Other current liabilities | 638 | 735 | 11,904 | 12,030 | 13,219 |
| TOTAL | $47,157 | $36,702 | $50,310 | $53,831 | $52,524 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60,000 | 50,000 | 50,000 | 58,824 | 68,824 |
| Other Non-Current Liabilities | 13,208 | 33,517 | 25,997 | 29,401 | 32,480 |
| TOTAL | $74,263 | $87,712 | $79,386 | $91,232 | $105,108 |
| Total Liabilities | $121,420 | $124,414 | $129,696 | $145,063 | $157,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,364 | 43,354 | 43,330 | 43,145 | 43,076 |
| Retained earnings | 180,701 | 174,044 | 162,375 | 136,073 | 109,294 |
| Other shareholders' equity | 198 | 1,808 | 1,760 | 1,399 | -1,860 |
| TOTAL | $328,302 | $322,156 | $309,473 | $278,867 | $247,629 |
| Total Liabilities And Equity | $449,722 | $446,570 | $439,169 | $423,930 | $405,261 |